doi:10.1186/s40168-015-0076-7
[1] [2] Systemic symptoms such as fatigue and headache are also recognised, and these may contribute to a flu-like feeling, especially when combined with reduced caloric intake and the body's adjustment to weight loss
The MHRA approved tirzepatide following rigorous evaluation of safety and efficacy data from the SURPASS clinical trial programme for diabetes and the SURMOUNT trials for weight management
Semaglutide acts on brain appetite centers , helping patients feel fuller for longer, which supports both glycemic control and weight reduction
In some cases, significant weight loss has been enough to correct low testosterone without medication
Association Between Semaglutide Therapy and Acne Severity in Patients with Type 2 Diabetes: A Case-control Study. Journal of Diabetes and Skin Health, 5(3), 132-139